Harvoni is a revolutionary medication used to treat chronic hepatitis C, offering high cure rates with a streamlined treatment process. However, the cost of Harvoni can be a significant concern for many patients.

As of now, the average retail Harvoni cost can exceed $30,000 for a typical 12-week treatment course. This figure can vary based on factors such as pharmacy location, insurance coverage, and any available discounts or patient assistance programs.

Many insurance plans cover Harvoni, but patients should check their specific coverage details, including copays and deductibles. For those without insurance or facing high out-of-pocket costs, several pharmaceutical companies offer financial assistance programs designed to help eligible patients afford their medications.

When considering Harvoni, it's essential to consult with your healthcare provider and pharmacist to explore all available options for managing costs, ensuring that financial barriers do not prevent access to this life-changing treatment.